Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years
Abstract A regulatory framework allowing legal access to medicinal cannabis (MC) products has operated in Australia since November 2016. MC…
Abstract A regulatory framework allowing legal access to medicinal cannabis (MC) products has operated in Australia since November 2016. MC…
Abstract Inflammation often develops from acute, chronic, or auto-inflammatory disorders that can lead to compromised organ function. Cannabis (Cannabis sativa)…
Abstract Background: Little is known about cannabis use for insomnia in individuals with depression, anxiety, and comorbid depression and anxiety.…
Abstract Concomitant use of cannabis with other drugs may lead to cannabis–drug interactions, mainly due to the pharmacokinetic mechanism involving…
Abstract Introduction: The cannabinoid Δ9-tetrahydrocannabinolic acid (Δ9-THCA) has long been suggested in review articles and anecdotal reports to be anticonvulsant;…
Abstract Background: In 2018, an innovative, State government‐funded cannabis medicines drug information service was established for health professionals in New…
Abstract Objective: This study sought to investigate the perceptions, barriers, and drivers associated with medicinal cannabis use among Australian women…
Abstract Cannabis is well-known for its numerous therapeutic activities, as demonstrated in pre-clinical and clinical studies primarily due to its…
Abstract Introduction: This phase I open-label study examined pharmacokinetics, safety, and tolerability of escalating doses of a novel combination cannabinoid…
Abstract Introduction: Despite widespread legalization, the impact of medicinal cannabis use on patient-level health and quality of life (QOL) has…